{"id": "article-23508_0", "title": "Inflammatory Back Pain -- Continuing Education Activity", "content": "Inflammatory back pain (IBP) is chronic pain\u00a0concentrated\u00a0in the\u00a0axial spine and sacroiliac joints,\u00a0distinguishing it from mechanical back pain\u00a0through specific diagnostic features. While strongly\u00a0linked\u00a0to inflammatory conditions,\u00a0IBP is not diagnostic.\u00a0IBP is a hallmark symptom of spondyloarthritis, characterized by insidious onset, morning stiffness, and improvement with exercise but not rest. Clinicians must recognize these distinctive features for early diagnosis and appropriate management.", "contents": "Inflammatory Back Pain -- Continuing Education Activity. Inflammatory back pain (IBP) is chronic pain\u00a0concentrated\u00a0in the\u00a0axial spine and sacroiliac joints,\u00a0distinguishing it from mechanical back pain\u00a0through specific diagnostic features. While strongly\u00a0linked\u00a0to inflammatory conditions,\u00a0IBP is not diagnostic.\u00a0IBP is a hallmark symptom of spondyloarthritis, characterized by insidious onset, morning stiffness, and improvement with exercise but not rest. Clinicians must recognize these distinctive features for early diagnosis and appropriate management."}
{"id": "article-23508_1", "title": "Inflammatory Back Pain -- Continuing Education Activity", "content": "This course discusses the association of IBP with ankylosing spondylitis and other seronegative spondyloarthropathies, including psoriatic arthritis, enteropathic arthropathy, juvenile idiopathic arthritis, and reactive arthritis. Patient characteristics, chronicity, and pain progression are also discussed, offering clinicians valuable insights to differentiate IBP from other causes and emphasizing a comprehensive approach to address the complexities of this complex pain syndrome associated with\u00a0spondyloarthritis.", "contents": "Inflammatory Back Pain -- Continuing Education Activity. This course discusses the association of IBP with ankylosing spondylitis and other seronegative spondyloarthropathies, including psoriatic arthritis, enteropathic arthropathy, juvenile idiopathic arthritis, and reactive arthritis. Patient characteristics, chronicity, and pain progression are also discussed, offering clinicians valuable insights to differentiate IBP from other causes and emphasizing a comprehensive approach to address the complexities of this complex pain syndrome associated with\u00a0spondyloarthritis."}
{"id": "article-23508_2", "title": "Inflammatory Back Pain -- Continuing Education Activity", "content": "Objectives: Identify\u00a0diagnostic features of inflammatory back pain to enable accurate differentiation from mechanical back pain. Screen for inflammatory back pain risk factors, including age, chronicity, and specific pain patterns. Implement multimodal treatment approaches. Communicate effectively with patients undergoing treatment for inflammatory back pain. Access free multiple choice questions on this topic.", "contents": "Inflammatory Back Pain -- Continuing Education Activity. Objectives: Identify\u00a0diagnostic features of inflammatory back pain to enable accurate differentiation from mechanical back pain. Screen for inflammatory back pain risk factors, including age, chronicity, and specific pain patterns. Implement multimodal treatment approaches. Communicate effectively with patients undergoing treatment for inflammatory back pain. Access free multiple choice questions on this topic."}
{"id": "article-23508_3", "title": "Inflammatory Back Pain -- Introduction", "content": "Inflammatory back pain (IBP) is chronic pain\u00a0concentrated\u00a0in the\u00a0axial spine and sacroiliac joints,\u00a0distinguishing it from mechanical back pain\u00a0through specific diagnostic features. While strongly\u00a0linked\u00a0to inflammatory conditions,\u00a0IBP is not diagnostic. Several key characteristics help differentiate IBP from other causes of back pain: Localization of pain: IBP\u00a0is typically localized on the axial spine, particularly the lumbar spine. Additionally, patients may experience alternating buttock pain from one side to another. Patient characteristics: The patient's characteristics, such as age and chronic pain, are crucial in distinguishing IBP. Associated with the onset of pain before the age of 40, persistent pain\u00a0lasts for 3 months or more. [1] [2] Pain progression: The progression of pain over time is another important factor in diagnosing IBP. The pain often follows an insidious course, gradually worsening over an extended period.", "contents": "Inflammatory Back Pain -- Introduction. Inflammatory back pain (IBP) is chronic pain\u00a0concentrated\u00a0in the\u00a0axial spine and sacroiliac joints,\u00a0distinguishing it from mechanical back pain\u00a0through specific diagnostic features. While strongly\u00a0linked\u00a0to inflammatory conditions,\u00a0IBP is not diagnostic. Several key characteristics help differentiate IBP from other causes of back pain: Localization of pain: IBP\u00a0is typically localized on the axial spine, particularly the lumbar spine. Additionally, patients may experience alternating buttock pain from one side to another. Patient characteristics: The patient's characteristics, such as age and chronic pain, are crucial in distinguishing IBP. Associated with the onset of pain before the age of 40, persistent pain\u00a0lasts for 3 months or more. [1] [2] Pain progression: The progression of pain over time is another important factor in diagnosing IBP. The pain often follows an insidious course, gradually worsening over an extended period."}
{"id": "article-23508_4", "title": "Inflammatory Back Pain -- Introduction", "content": "Morning Stiffness: Patients with IBP commonly experience morning stiffness, which tends to improve with movement or exercise. This significant feature helps differentiate it from\u00a0other forms of back pain. Association with inflammatory conditions: While the classic association\u00a0is with ankylosing spondylitis, IBP may also be present in other seronegative spondyloarthropathies such as psoriatic arthritis (PsA), enteropathic arthropathy, juvenile idiopathic arthritis (RIA), and reactive arthritis. Undifferentiated causes: In some cases, the cause of IBP may be undifferentiated, given the absence or combination of diagnostic features of any of these conditions. [3] [4]", "contents": "Inflammatory Back Pain -- Introduction. Morning Stiffness: Patients with IBP commonly experience morning stiffness, which tends to improve with movement or exercise. This significant feature helps differentiate it from\u00a0other forms of back pain. Association with inflammatory conditions: While the classic association\u00a0is with ankylosing spondylitis, IBP may also be present in other seronegative spondyloarthropathies such as psoriatic arthritis (PsA), enteropathic arthropathy, juvenile idiopathic arthritis (RIA), and reactive arthritis. Undifferentiated causes: In some cases, the cause of IBP may be undifferentiated, given the absence or combination of diagnostic features of any of these conditions. [3] [4]"}
{"id": "article-23508_5", "title": "Inflammatory Back Pain -- Etiology", "content": "The identification of seronegative spondyloarthropathies\u00a0often follows the presentation of IBP. The etiology of these conditions is complex, typically linked to a systemic inflammatory response\u00a0triggered by a known or unknown source. This systemic inflammation induces local tissue alterations that\u00a0may persist in the joint environment. The persistence of inflammation, mediated by pathways like interleukin-17 (IL-17) and tumor necrosis factor (TNF), contributes to an ongoing cycle of imbalanced bone remodeling, leading to axial bone loss. [2]", "contents": "Inflammatory Back Pain -- Etiology. The identification of seronegative spondyloarthropathies\u00a0often follows the presentation of IBP. The etiology of these conditions is complex, typically linked to a systemic inflammatory response\u00a0triggered by a known or unknown source. This systemic inflammation induces local tissue alterations that\u00a0may persist in the joint environment. The persistence of inflammation, mediated by pathways like interleukin-17 (IL-17) and tumor necrosis factor (TNF), contributes to an ongoing cycle of imbalanced bone remodeling, leading to axial bone loss. [2]"}
{"id": "article-23508_6", "title": "Inflammatory Back Pain -- Etiology", "content": "The inflammatory\u00a0changes and subsequent structural alterations, classically observed in imaging through vertebral bone fusion in conditions like ankylosing spondylitis,\u00a0provide insight into the insidious onset of chronic pain observed in patients with IBP. These manifestations have been pivotal in directing research toward potential intervention strategies. [1] [5]", "contents": "Inflammatory Back Pain -- Etiology. The inflammatory\u00a0changes and subsequent structural alterations, classically observed in imaging through vertebral bone fusion in conditions like ankylosing spondylitis,\u00a0provide insight into the insidious onset of chronic pain observed in patients with IBP. These manifestations have been pivotal in directing research toward potential intervention strategies. [1] [5]"}
{"id": "article-23508_7", "title": "Inflammatory Back Pain -- Epidemiology", "content": "The assessment of IBP\u00a0prevalence in the US for adults aged 20 to 69 is\u00a0approximately 5% to 6%. [6] However, a\u00a0gap exists between the prevalence of IBP and a relatively lower prevalence of spondyloarthropathies in the US,\u00a0ranging from only\u00a00.9% to 1.4%. Studies conducted in Asia\u00a0reveal an even lower incidence of ankylosing spondylitis in that population, near 0.001%. Further, only 36% of Asian populations\u00a0experiencing\u00a0IBP meet the criteria for spondyloarthropathy. [7] This gap between the prevalence of IBP and seronegative spondyloarthropathy has\u00a0prompted some researchers to explore\u00a0other potential causes or\u00a0propose that\u00a0IBP may be distinct\u00a0from other inflammatory immune-mediated conditions.", "contents": "Inflammatory Back Pain -- Epidemiology. The assessment of IBP\u00a0prevalence in the US for adults aged 20 to 69 is\u00a0approximately 5% to 6%. [6] However, a\u00a0gap exists between the prevalence of IBP and a relatively lower prevalence of spondyloarthropathies in the US,\u00a0ranging from only\u00a00.9% to 1.4%. Studies conducted in Asia\u00a0reveal an even lower incidence of ankylosing spondylitis in that population, near 0.001%. Further, only 36% of Asian populations\u00a0experiencing\u00a0IBP meet the criteria for spondyloarthropathy. [7] This gap between the prevalence of IBP and seronegative spondyloarthropathy has\u00a0prompted some researchers to explore\u00a0other potential causes or\u00a0propose that\u00a0IBP may be distinct\u00a0from other inflammatory immune-mediated conditions."}
{"id": "article-23508_8", "title": "Inflammatory Back Pain -- Epidemiology", "content": "A\u00a0UK study\u00a0observed\u00a0a minimum prevalence of IBP\u00a0ranging from 1.7% to 3.4% in primary care. [6] Similarly, a study conducted\u00a0in Mexico\u00a0reported\u00a0a prevalence of 3% for IBP in that population. [6] Notably, the frequency of IBP in different populations varies considerably depending on the diagnostic criteria employed; however, in most studies, the prevalence does not exceed 8%.", "contents": "Inflammatory Back Pain -- Epidemiology. A\u00a0UK study\u00a0observed\u00a0a minimum prevalence of IBP\u00a0ranging from 1.7% to 3.4% in primary care. [6] Similarly, a study conducted\u00a0in Mexico\u00a0reported\u00a0a prevalence of 3% for IBP in that population. [6] Notably, the frequency of IBP in different populations varies considerably depending on the diagnostic criteria employed; however, in most studies, the prevalence does not exceed 8%."}
{"id": "article-23508_9", "title": "Inflammatory Back Pain -- Epidemiology", "content": "In at least 1 large study, IBP was found to be more prevalent among non-Hispanic white individuals than non-Hispanic black\u00a0individuals\u00a0(5.9% versus\u00a03.3%).\u00a0Limited evidence currently supports the existence of a significant difference in IBP rates based on gender or age group. [8]", "contents": "Inflammatory Back Pain -- Epidemiology. In at least 1 large study, IBP was found to be more prevalent among non-Hispanic white individuals than non-Hispanic black\u00a0individuals\u00a0(5.9% versus\u00a03.3%).\u00a0Limited evidence currently supports the existence of a significant difference in IBP rates based on gender or age group. [8]"}
{"id": "article-23508_10", "title": "Inflammatory Back Pain -- Pathophysiology", "content": "IBP\u00a0is a chronic pain condition characterized by an insidious onset of pain localized to the lower back and buttocks.\u00a0The\u00a0pathophysiology stems from a systemic inflammatory response to\u00a0an insult, leading to the localization of inflammatory mediators\u00a0in the axial skeletal joints and\u00a0triggering proinflammatory intracellular changes. This\u00a0persistent inflammatory condition results in a cycle of unbalanced bone remodeling associated with bone loss and\u00a0potential for bone fusion.", "contents": "Inflammatory Back Pain -- Pathophysiology. IBP\u00a0is a chronic pain condition characterized by an insidious onset of pain localized to the lower back and buttocks.\u00a0The\u00a0pathophysiology stems from a systemic inflammatory response to\u00a0an insult, leading to the localization of inflammatory mediators\u00a0in the axial skeletal joints and\u00a0triggering proinflammatory intracellular changes. This\u00a0persistent inflammatory condition results in a cycle of unbalanced bone remodeling associated with bone loss and\u00a0potential for bone fusion."}
{"id": "article-23508_11", "title": "Inflammatory Back Pain -- Pathophysiology", "content": "Ankylosing spondylitis: Ankylosing spondylitis and other forms of spondyloarthritis affect the axial skeleton, involving the interplay between bone, ligaments, tendons, and cartilage. SpA-specific gut microbiota activates innate lymphoid cells that produce proinflammatory cytokines. Inflammatory processes occurring in the entheses and joints\u00a0contribute to\u00a0bone erosion,\u00a0while mechanical stress\u00a0triggers the generation of\u00a0IL-17. The human leukocyte antigen (HLA) B27 gene plays a significant\u00a0role in several key pathogenic processes, although non-HLA genes have also been identified. [9] Inflammation initiates changes in bone, leading to new bone formation, such as syndesmophytes.", "contents": "Inflammatory Back Pain -- Pathophysiology. Ankylosing spondylitis: Ankylosing spondylitis and other forms of spondyloarthritis affect the axial skeleton, involving the interplay between bone, ligaments, tendons, and cartilage. SpA-specific gut microbiota activates innate lymphoid cells that produce proinflammatory cytokines. Inflammatory processes occurring in the entheses and joints\u00a0contribute to\u00a0bone erosion,\u00a0while mechanical stress\u00a0triggers the generation of\u00a0IL-17. The human leukocyte antigen (HLA) B27 gene plays a significant\u00a0role in several key pathogenic processes, although non-HLA genes have also been identified. [9] Inflammation initiates changes in bone, leading to new bone formation, such as syndesmophytes."}
{"id": "article-23508_12", "title": "Inflammatory Back Pain -- Pathophysiology", "content": "PsA: The cause of PsA is\u00a0unknown, although some factors have been suggested. Genetic factors play a role in PsA pathogenesis, as evidenced by a higher prevalence\u00a0within certain families and among twins and an association with specific histocompatibility antigens. Additionally, several environmental factors, including infections and trauma, have been linked to PsA. Immunologic mechanisms are\u00a0indicated by the shared inflammatory response observed in\u00a0psoriatic skin and synovial lesions and inflammation in soft tissues and the spine, features shared with axial spondyloarthritis.", "contents": "Inflammatory Back Pain -- Pathophysiology. PsA: The cause of PsA is\u00a0unknown, although some factors have been suggested. Genetic factors play a role in PsA pathogenesis, as evidenced by a higher prevalence\u00a0within certain families and among twins and an association with specific histocompatibility antigens. Additionally, several environmental factors, including infections and trauma, have been linked to PsA. Immunologic mechanisms are\u00a0indicated by the shared inflammatory response observed in\u00a0psoriatic skin and synovial lesions and inflammation in soft tissues and the spine, features shared with axial spondyloarthritis."}
{"id": "article-23508_13", "title": "Inflammatory Back Pain -- Pathophysiology", "content": "Enteropathic arthropathy: The development of arthritis and inflammatory bowel disease (IBD) may involve the influence of gastrointestinal bacteria. For example, in a study involving rats raised in a germ-free environment and transgenic for the HLA-B27, there were\u00a0no reported\u00a0instances of\u00a0joint or intestinal inflammation. [10] Moreover,\u00a0individuals with Crohn disease and ankylosing spondylitis\u00a0exhibited\u00a0increased levels of immunoglobulin M (IgM) and IgG antibodies to collagen types I, III, IV, V, and Klebsiella pneumoniae compared to healthy controls. [11] Additionally, these patients\u00a0display a positive antibody response to K pneumoniae serotypes, a phenomenon not observed in patients with celiac disease or healthy controls.", "contents": "Inflammatory Back Pain -- Pathophysiology. Enteropathic arthropathy: The development of arthritis and inflammatory bowel disease (IBD) may involve the influence of gastrointestinal bacteria. For example, in a study involving rats raised in a germ-free environment and transgenic for the HLA-B27, there were\u00a0no reported\u00a0instances of\u00a0joint or intestinal inflammation. [10] Moreover,\u00a0individuals with Crohn disease and ankylosing spondylitis\u00a0exhibited\u00a0increased levels of immunoglobulin M (IgM) and IgG antibodies to collagen types I, III, IV, V, and Klebsiella pneumoniae compared to healthy controls. [11] Additionally, these patients\u00a0display a positive antibody response to K pneumoniae serotypes, a phenomenon not observed in patients with celiac disease or healthy controls."}
{"id": "article-23508_14", "title": "Inflammatory Back Pain -- Pathophysiology", "content": "JIA: Joint damage\u00a0in JIA arises from\u00a0the formation of inflamed synovial tissue,\u00a0known as pannus. This process involves synoviocyte proliferation and infiltration by inflammatory cells. Vascular factors, cytokines, adhesion molecules, and chemokines facilitate infiltration into the synovium, and inflammatory cells are also present in the synovial fluid. Consequently, the pannus\u00a0extends and adheres to intraarticular cartilage,\u00a0resulting in\u00a0cartilage degradation at the pannus-cartilage junctions. [12] Reactive arthritis: Major causative organisms for reactive arthritis include Campylobacter , Salmonella , and Shigella . [13]", "contents": "Inflammatory Back Pain -- Pathophysiology. JIA: Joint damage\u00a0in JIA arises from\u00a0the formation of inflamed synovial tissue,\u00a0known as pannus. This process involves synoviocyte proliferation and infiltration by inflammatory cells. Vascular factors, cytokines, adhesion molecules, and chemokines facilitate infiltration into the synovium, and inflammatory cells are also present in the synovial fluid. Consequently, the pannus\u00a0extends and adheres to intraarticular cartilage,\u00a0resulting in\u00a0cartilage degradation at the pannus-cartilage junctions. [12] Reactive arthritis: Major causative organisms for reactive arthritis include Campylobacter , Salmonella , and Shigella . [13]"}
{"id": "article-23508_15", "title": "Inflammatory Back Pain -- Histopathology", "content": "Though not a diagnostic criterion, IBP has been\u00a0established as a\u00a0sentinel condition for seronegative spondyloarthropathies. Histopathologic\u00a0studies\u00a0in patients with spondyloarthropathies, compared to\u00a0those with rheumatoid arthritis,\u00a0reveal\u00a0heightened vascularity, the proliferation of CD163+ macrophages, and increased levels of polymorphonuclear leukocytes. [14] The synovial membrane\u00a0undergoes\u00a0inflammation and thickening due to the infiltration of immune cells such as T cells, B cells, and macrophages. These cells release cytokines such as TNF-\u03b1 and interleukins (IL-1, IL-6, and IL-17), exacerbating inflammation and contributing to tissue damage. In addition to synovial inflammation, IBP is\u00a0associated with erosion of the adjacent bone tissue.\u00a0This erosion results from the activation of osteoclasts, triggered by the release of cytokines such as TNF-\u03b1 and receptor activator of nuclear factor kappa-B ligand (RANKL) by immune cells.", "contents": "Inflammatory Back Pain -- Histopathology. Though not a diagnostic criterion, IBP has been\u00a0established as a\u00a0sentinel condition for seronegative spondyloarthropathies. Histopathologic\u00a0studies\u00a0in patients with spondyloarthropathies, compared to\u00a0those with rheumatoid arthritis,\u00a0reveal\u00a0heightened vascularity, the proliferation of CD163+ macrophages, and increased levels of polymorphonuclear leukocytes. [14] The synovial membrane\u00a0undergoes\u00a0inflammation and thickening due to the infiltration of immune cells such as T cells, B cells, and macrophages. These cells release cytokines such as TNF-\u03b1 and interleukins (IL-1, IL-6, and IL-17), exacerbating inflammation and contributing to tissue damage. In addition to synovial inflammation, IBP is\u00a0associated with erosion of the adjacent bone tissue.\u00a0This erosion results from the activation of osteoclasts, triggered by the release of cytokines such as TNF-\u03b1 and receptor activator of nuclear factor kappa-B ligand (RANKL) by immune cells."}
{"id": "article-23508_16", "title": "Inflammatory Back Pain -- History and Physical", "content": "IBP\u00a0is differentiated from mechanical back pain by its insidious onset, alleviation\u00a0with exercise,\u00a0absence of improvement with rest, and nocturnal pain that improves\u00a0upon rising and movement. Its connection to\u00a0seronegative spondyloarthropathies suggests that an inciting illness or systemic inflammatory process might precede IBP. [3]", "contents": "Inflammatory Back Pain -- History and Physical. IBP\u00a0is differentiated from mechanical back pain by its insidious onset, alleviation\u00a0with exercise,\u00a0absence of improvement with rest, and nocturnal pain that improves\u00a0upon rising and movement. Its connection to\u00a0seronegative spondyloarthropathies suggests that an inciting illness or systemic inflammatory process might precede IBP. [3]"}
{"id": "article-23508_17", "title": "Inflammatory Back Pain -- Evaluation", "content": "When distinguished from other causes of back pain using accepted diagnostic criteria,\u00a0IBP can\u00a0serve as a referral criterion for rheumatologic evaluation. This is especially pertinent when supported by a positive HLA-B27 laboratory test and sacroiliitis evident\u00a0in imaging studies\u00a0that align with the established\u00a0pain criteria.", "contents": "Inflammatory Back Pain -- Evaluation. When distinguished from other causes of back pain using accepted diagnostic criteria,\u00a0IBP can\u00a0serve as a referral criterion for rheumatologic evaluation. This is especially pertinent when supported by a positive HLA-B27 laboratory test and sacroiliitis evident\u00a0in imaging studies\u00a0that align with the established\u00a0pain criteria."}
{"id": "article-23508_18", "title": "Inflammatory Back Pain -- Evaluation", "content": "Up to\u00a050% of patients with axial spondyloarthropathy\u00a0may exhibit an\u00a0increased acute phase response, marked by elevated erythrocyte sedimentation rate and C-reactive protein levels. However, similar elevations in these values are also typically associated with rheumatoid arthritis. [15] [16]", "contents": "Inflammatory Back Pain -- Evaluation. Up to\u00a050% of patients with axial spondyloarthropathy\u00a0may exhibit an\u00a0increased acute phase response, marked by elevated erythrocyte sedimentation rate and C-reactive protein levels. However, similar elevations in these values are also typically associated with rheumatoid arthritis. [15] [16]"}
{"id": "article-23508_19", "title": "Inflammatory Back Pain -- Evaluation", "content": "Ankylosing spondylitis: A positive Schober test is observed during the physical examination. This test evaluates the mobility and flexibility of the lumbar spine by marking\u00a02 points on the lower back\u20141\u00a0point 10 cm above the sacrum and the other 5 cm above the first mark. The distance between these\u00a02 points is measured while the patient stands upright and again while bending forward as much as possible. A Schober test is considered positive if there is less than a 5 cm increase in distance between the\u00a02 marks on the lower back when the patient bends forward. [17]  Radiographic findings of the sacroiliac (SI) joints can range from subtle joint space narrowing and sclerosis to erosive changes. Eventually, this\u00a0progression may lead to bony ankylosis (fusion).\u00a0For\u00a0diagnostic purposes, ankylosing spondylitis is\u00a0confirmed with the combination of at least\u00a01 associated clinical criterion and at least\u00a01 imaging criterion, meeting the severity and duration criteria for findings.", "contents": "Inflammatory Back Pain -- Evaluation. Ankylosing spondylitis: A positive Schober test is observed during the physical examination. This test evaluates the mobility and flexibility of the lumbar spine by marking\u00a02 points on the lower back\u20141\u00a0point 10 cm above the sacrum and the other 5 cm above the first mark. The distance between these\u00a02 points is measured while the patient stands upright and again while bending forward as much as possible. A Schober test is considered positive if there is less than a 5 cm increase in distance between the\u00a02 marks on the lower back when the patient bends forward. [17]  Radiographic findings of the sacroiliac (SI) joints can range from subtle joint space narrowing and sclerosis to erosive changes. Eventually, this\u00a0progression may lead to bony ankylosis (fusion).\u00a0For\u00a0diagnostic purposes, ankylosing spondylitis is\u00a0confirmed with the combination of at least\u00a01 associated clinical criterion and at least\u00a01 imaging criterion, meeting the severity and duration criteria for findings."}
{"id": "article-23508_20", "title": "Inflammatory Back Pain -- Evaluation", "content": "PsA: Magnetic resonance imaging (MRI) of axial\u00a0SI joints shows bone marrow edema in the iliac and sacral bones, sclerosis, chronic changes in periarticular fat accumulation, erosions, and new bone formation. Enteropathic arthropathy: X-rays can\u00a0reveal joint abnormalities like swelling and bone loss,\u00a0although these\u00a0manifestations can also be present in patients without IBD symptoms.\u00a0MRI effectively detects joint changes but may not\u00a0consistently correlate with back pain. Therefore, its\u00a0recommendation is reserved for patients\u00a0exhibiting back pain and IBD symptoms. JIA: Patients with JIA often\u00a0exhibit a positive antinuclear antibody (ANA), an elevated erythrocyte sedimentation rate (\u226540 mm/hour), hypergammaglobulinemia, and anemia (hemoglobin concentration \u226411 g/dL) may be observed. [12]", "contents": "Inflammatory Back Pain -- Evaluation. PsA: Magnetic resonance imaging (MRI) of axial\u00a0SI joints shows bone marrow edema in the iliac and sacral bones, sclerosis, chronic changes in periarticular fat accumulation, erosions, and new bone formation. Enteropathic arthropathy: X-rays can\u00a0reveal joint abnormalities like swelling and bone loss,\u00a0although these\u00a0manifestations can also be present in patients without IBD symptoms.\u00a0MRI effectively detects joint changes but may not\u00a0consistently correlate with back pain. Therefore, its\u00a0recommendation is reserved for patients\u00a0exhibiting back pain and IBD symptoms. JIA: Patients with JIA often\u00a0exhibit a positive antinuclear antibody (ANA), an elevated erythrocyte sedimentation rate (\u226540 mm/hour), hypergammaglobulinemia, and anemia (hemoglobin concentration \u226411 g/dL) may be observed. [12]"}
{"id": "article-23508_21", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "A referral to a rheumatologic specialist may be warranted after establishing a diagnosis of IBP using accepted criteria, particularly\u00a0when accompanied by\u00a0positive HLA-B27 testing and confirmation of sacroiliitis\u00a0through imaging. Timely and collaborative efforts between healthcare professionals contribute to a more effective and patient-centered approach to addressing the complexities of\u00a0IBP and its underlying causes.", "contents": "Inflammatory Back Pain -- Treatment / Management. A referral to a rheumatologic specialist may be warranted after establishing a diagnosis of IBP using accepted criteria, particularly\u00a0when accompanied by\u00a0positive HLA-B27 testing and confirmation of sacroiliitis\u00a0through imaging. Timely and collaborative efforts between healthcare professionals contribute to a more effective and patient-centered approach to addressing the complexities of\u00a0IBP and its underlying causes."}
{"id": "article-23508_22", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "The initial treatment for IBP\u00a0begins with patient education\u00a0regarding the nature of their condition and the expected course. Patients should be informed regarding the possibility of associated conditions, prompting further investigation into underlying causes through laboratory evaluation and imaging.\u00a0Emphasizing the importance\u00a0of smoking cessation is crucial. Additionally, discussing sources of psychosocial support is essential.\u00a0Physical therapy consultation is often recommended, given the favorable response of IBP and its associated inflammatory\u00a0conditions to\u00a0exercise and movement therapies.", "contents": "Inflammatory Back Pain -- Treatment / Management. The initial treatment for IBP\u00a0begins with patient education\u00a0regarding the nature of their condition and the expected course. Patients should be informed regarding the possibility of associated conditions, prompting further investigation into underlying causes through laboratory evaluation and imaging.\u00a0Emphasizing the importance\u00a0of smoking cessation is crucial. Additionally, discussing sources of psychosocial support is essential.\u00a0Physical therapy consultation is often recommended, given the favorable response of IBP and its associated inflammatory\u00a0conditions to\u00a0exercise and movement therapies."}
{"id": "article-23508_23", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "The initial pharmacologic\u00a0approach\u00a0for IBP, whether\u00a0symptomatic of\u00a0axial spondyloarthropathy or not, typically involves a trial of nonsteroidal anti-inflammatory drug (NSAID) therapy,\u00a0often necessitating a\u00a0maximum dose.\u00a0This initial treatment should\u00a0span 2\u00a0to\u00a04 weeks, during which effectiveness is evaluated. Identifying\u00a0an effective medication can be utilized as needed for\u00a0symptom control.", "contents": "Inflammatory Back Pain -- Treatment / Management. The initial pharmacologic\u00a0approach\u00a0for IBP, whether\u00a0symptomatic of\u00a0axial spondyloarthropathy or not, typically involves a trial of nonsteroidal anti-inflammatory drug (NSAID) therapy,\u00a0often necessitating a\u00a0maximum dose.\u00a0This initial treatment should\u00a0span 2\u00a0to\u00a04 weeks, during which effectiveness is evaluated. Identifying\u00a0an effective medication can be utilized as needed for\u00a0symptom control."}
{"id": "article-23508_24", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "In cases where NSAID therapy proves ineffective for symptom control in patients with known axial spondyloarthropathy, the next medications include TNF inhibitors or an alternative, such as secukinumab. [18] If a patient initially responds to a TNF inhibitor but experiences a loss of efficacy, a switch to a second TNF inhibitor is recommended. However, for patients\u00a0intolerant to 1 or 2\u00a0TNF inhibitors or with an inadequate response (typically after\u00a03 months of therapy for each TNF inhibitor used), it is\u00a0advisable\u00a0to switch to an anti-IL-17 antibody like ixekizumab or secukinumab or a JAK inhibitor such as tofacitinib or upadacitinib.\u00a0These medication classes compromise the\u00a0immune response, necessitating careful consideration of immune function,\u00a0malignancy diagnosis, heart health, or coexisting demyelinating diseases.", "contents": "Inflammatory Back Pain -- Treatment / Management. In cases where NSAID therapy proves ineffective for symptom control in patients with known axial spondyloarthropathy, the next medications include TNF inhibitors or an alternative, such as secukinumab. [18] If a patient initially responds to a TNF inhibitor but experiences a loss of efficacy, a switch to a second TNF inhibitor is recommended. However, for patients\u00a0intolerant to 1 or 2\u00a0TNF inhibitors or with an inadequate response (typically after\u00a03 months of therapy for each TNF inhibitor used), it is\u00a0advisable\u00a0to switch to an anti-IL-17 antibody like ixekizumab or secukinumab or a JAK inhibitor such as tofacitinib or upadacitinib.\u00a0These medication classes compromise the\u00a0immune response, necessitating careful consideration of immune function,\u00a0malignancy diagnosis, heart health, or coexisting demyelinating diseases."}
{"id": "article-23508_25", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "Surgical intervention may be indicated in\u00a0cases of IBP with axial spondyloarthritis\u00a0under various circumstances, such as\u00a0severe hip involvement\u00a0causing\u00a0persistent pain or severe limitation in mobility and quality of life, atlantoaxial subluxation with neurologic impairment, and severe flexion deformities\u00a0resulting in impaired ability to\u00a0gaze in a forward direction. [19] [20]", "contents": "Inflammatory Back Pain -- Treatment / Management. Surgical intervention may be indicated in\u00a0cases of IBP with axial spondyloarthritis\u00a0under various circumstances, such as\u00a0severe hip involvement\u00a0causing\u00a0persistent pain or severe limitation in mobility and quality of life, atlantoaxial subluxation with neurologic impairment, and severe flexion deformities\u00a0resulting in impaired ability to\u00a0gaze in a forward direction. [19] [20]"}
{"id": "article-23508_26", "title": "Inflammatory Back Pain -- Treatment / Management", "content": "It is crucial to consider the unique aspects of each condition, including its progression and response to treatment, to ensure comprehensive and effective management. Please refer to separate resources for more specific information on managing individual conditions. [9] [12] [21]", "contents": "Inflammatory Back Pain -- Treatment / Management. It is crucial to consider the unique aspects of each condition, including its progression and response to treatment, to ensure comprehensive and effective management. Please refer to separate resources for more specific information on managing individual conditions. [9] [12] [21]"}
{"id": "article-23508_27", "title": "Inflammatory Back Pain -- Differential Diagnosis", "content": "The differential diagnosis of\u00a0IBP encompasses\u00a0mechanical, nonmechanical, and visceral sources. It is crucial to exclude\u00a0pain sources\u00a0stemming from cancer or vertebral body compression fractures. Recall that the characteristic features of IBP\u00a0include\u00a0age of onset less than 40, back pain duration\u00a0exceeding\u00a03 months, insidious onset, morning stiffness, and improvement with exercise. In contrast, causes of mechanical back pain\u00a0typically exacerbate\u00a0with movement and exercise and\u00a0often correlate with injury, presenting a more acute onset. [22]", "contents": "Inflammatory Back Pain -- Differential Diagnosis. The differential diagnosis of\u00a0IBP encompasses\u00a0mechanical, nonmechanical, and visceral sources. It is crucial to exclude\u00a0pain sources\u00a0stemming from cancer or vertebral body compression fractures. Recall that the characteristic features of IBP\u00a0include\u00a0age of onset less than 40, back pain duration\u00a0exceeding\u00a03 months, insidious onset, morning stiffness, and improvement with exercise. In contrast, causes of mechanical back pain\u00a0typically exacerbate\u00a0with movement and exercise and\u00a0often correlate with injury, presenting a more acute onset. [22]"}
{"id": "article-23508_28", "title": "Inflammatory Back Pain -- Differential Diagnosis", "content": "Patients should undergo an assessment for neurologic deficits that may\u00a0indicate compression of the spinal cord or cauda equina syndrome. Additionally, patients with a high clinical suspicion of vertebral osteomyelitis or epidural abscess warrant an immediate MRI.", "contents": "Inflammatory Back Pain -- Differential Diagnosis. Patients should undergo an assessment for neurologic deficits that may\u00a0indicate compression of the spinal cord or cauda equina syndrome. Additionally, patients with a high clinical suspicion of vertebral osteomyelitis or epidural abscess warrant an immediate MRI."}
{"id": "article-23508_29", "title": "Inflammatory Back Pain -- Differential Diagnosis", "content": "In a study\u00a0assessing the\u00a0efficacy of\u00a0traditionally\u00a0considered indicators of\u00a0cancer as the cause of back pain, it was discovered that a history of malignancy and strong clinical suspicion of cancer were the most\u00a0valuable factors\u00a0directing\u00a0the evaluation\u00a0toward a potential cancer-related origin of\u00a0back pain. [23]", "contents": "Inflammatory Back Pain -- Differential Diagnosis. In a study\u00a0assessing the\u00a0efficacy of\u00a0traditionally\u00a0considered indicators of\u00a0cancer as the cause of back pain, it was discovered that a history of malignancy and strong clinical suspicion of cancer were the most\u00a0valuable factors\u00a0directing\u00a0the evaluation\u00a0toward a potential cancer-related origin of\u00a0back pain. [23]"}
{"id": "article-23508_30", "title": "Inflammatory Back Pain -- Prognosis", "content": "NSAIDs constitute the first-line treatment for seronegative spondyloarthropathies, showcasing\u00a0substantial efficacy in alleviating\u00a0IBP. Additionally, NSAIDs have proven effective in enhancing the duration of morning stiffness and chest expansion in related arthropathies. When integrated with other demonstrated effective interventions, such as exercise and physical therapy, these medications can significantly improve\u00a0the overall quality of life for patients experiencing IBP. [24] [25]", "contents": "Inflammatory Back Pain -- Prognosis. NSAIDs constitute the first-line treatment for seronegative spondyloarthropathies, showcasing\u00a0substantial efficacy in alleviating\u00a0IBP. Additionally, NSAIDs have proven effective in enhancing the duration of morning stiffness and chest expansion in related arthropathies. When integrated with other demonstrated effective interventions, such as exercise and physical therapy, these medications can significantly improve\u00a0the overall quality of life for patients experiencing IBP. [24] [25]"}
{"id": "article-23508_31", "title": "Inflammatory Back Pain -- Prognosis", "content": "While\u00a0direct evidence linking\u00a0IBP\u00a0to increased mortality is limited, ankylosing spondylitis and other spondyloarthropathies involving the axial spine\u00a0are associated with\u00a0a 36% to 76% increased risk\u00a0of acute coronary syndrome (ACS) and a 50% increased risk of venous thromboembolism. Notably, female patients with PsA demonstrate\u00a0nearly double the risk of ACS compared to the general population. However, given the relatively young age\u00a0at which these diseases and associated IBP manifest, the absolute risks of ACS, venous thromboembolism, or stroke in these populations\u00a0remain modest. [26]", "contents": "Inflammatory Back Pain -- Prognosis. While\u00a0direct evidence linking\u00a0IBP\u00a0to increased mortality is limited, ankylosing spondylitis and other spondyloarthropathies involving the axial spine\u00a0are associated with\u00a0a 36% to 76% increased risk\u00a0of acute coronary syndrome (ACS) and a 50% increased risk of venous thromboembolism. Notably, female patients with PsA demonstrate\u00a0nearly double the risk of ACS compared to the general population. However, given the relatively young age\u00a0at which these diseases and associated IBP manifest, the absolute risks of ACS, venous thromboembolism, or stroke in these populations\u00a0remain modest. [26]"}
{"id": "article-23508_32", "title": "Inflammatory Back Pain -- Complications", "content": "The immunologically mediated process associated with IBP also correlates with a cycle of unbalanced bone remodeling, leading to osteoporosis, which becomes notable within the first 10 years of diagnosis.\u00a0Individuals with\u00a0ankylosing spondylitis face twice\u00a0the\u00a0likelihood of experiencing vertebral fractures as the general population, with extensions most commonly occurring in the cervical region. [27] Spinal cord injury is 11 times more common in ankylosing spondylitis, and patients with long-standing disease are at an increased risk of cauda equine syndrome. Additionally, individuals with axial spondyloarthropathy may be at higher risk of renal disease, with an 8% increase in abnormal urinalysis than the general population. [28] [29] [30]", "contents": "Inflammatory Back Pain -- Complications. The immunologically mediated process associated with IBP also correlates with a cycle of unbalanced bone remodeling, leading to osteoporosis, which becomes notable within the first 10 years of diagnosis.\u00a0Individuals with\u00a0ankylosing spondylitis face twice\u00a0the\u00a0likelihood of experiencing vertebral fractures as the general population, with extensions most commonly occurring in the cervical region. [27] Spinal cord injury is 11 times more common in ankylosing spondylitis, and patients with long-standing disease are at an increased risk of cauda equine syndrome. Additionally, individuals with axial spondyloarthropathy may be at higher risk of renal disease, with an 8% increase in abnormal urinalysis than the general population. [28] [29] [30]"}
{"id": "article-23508_33", "title": "Inflammatory Back Pain -- Complications", "content": "The chronic\u00a0use of\u00a0NSAIDs for patients with IBP carries associations with various possible complications. NSAIDs have links\u00a0to the exacerbation of peptic ulcer disease, an increased risk of cardiovascular events in at-risk populations, incitement of renal injury or failure, and exacerbation of existing reactive airway disease. Initiating NSAID administration should involve careful consideration of the patient\u2019s underlying disease process associated with IBP, other comorbid illnesses, and\u00a0concurrent medications, particularly glucocorticoids, anticoagulants, diuretics, and selective serotonin reuptake inhibitors (SSRIs). [31] [32]", "contents": "Inflammatory Back Pain -- Complications. The chronic\u00a0use of\u00a0NSAIDs for patients with IBP carries associations with various possible complications. NSAIDs have links\u00a0to the exacerbation of peptic ulcer disease, an increased risk of cardiovascular events in at-risk populations, incitement of renal injury or failure, and exacerbation of existing reactive airway disease. Initiating NSAID administration should involve careful consideration of the patient\u2019s underlying disease process associated with IBP, other comorbid illnesses, and\u00a0concurrent medications, particularly glucocorticoids, anticoagulants, diuretics, and selective serotonin reuptake inhibitors (SSRIs). [31] [32]"}
{"id": "article-23508_34", "title": "Inflammatory Back Pain -- Consultations", "content": "After confirming\u00a0the diagnosis of\u00a0IBP\u00a0using accepted criteria, a referral to a rheumatologic specialist may be indicated, particularly in those with positive HLA-B27 testing and confirmation of sacroiliitis\u00a0by imaging. In addition, a physical therapy referral is likely warranted as\u00a0IBP and its associated inflammatory illnesses\u00a0have shown\u00a0favorable responses to exercise and movement therapies.\u00a0This multidisciplinary approach aims to optimize patient outcomes and enhance overall well-being.", "contents": "Inflammatory Back Pain -- Consultations. After confirming\u00a0the diagnosis of\u00a0IBP\u00a0using accepted criteria, a referral to a rheumatologic specialist may be indicated, particularly in those with positive HLA-B27 testing and confirmation of sacroiliitis\u00a0by imaging. In addition, a physical therapy referral is likely warranted as\u00a0IBP and its associated inflammatory illnesses\u00a0have shown\u00a0favorable responses to exercise and movement therapies.\u00a0This multidisciplinary approach aims to optimize patient outcomes and enhance overall well-being."}
{"id": "article-23508_35", "title": "Inflammatory Back Pain -- Deterrence and Patient Education", "content": "The initial\u00a0intervention for patients with\u00a0IBP should begin with education, providing insights into the\u00a0anticipated course of\u00a0the condition and emphasizing the need for further evaluation\u00a0to identify potential sources of the inflammatory process. Patients should be advised to cease smoking, as it may exacerbate symptoms, and they should receive referrals to sources of psychosocial support. Notably, physical therapy, focusing on exercise and postural training, is an essential component of the treatment plan, as these interventions can offer significant benefits in managing the course of the disease. [19]", "contents": "Inflammatory Back Pain -- Deterrence and Patient Education. The initial\u00a0intervention for patients with\u00a0IBP should begin with education, providing insights into the\u00a0anticipated course of\u00a0the condition and emphasizing the need for further evaluation\u00a0to identify potential sources of the inflammatory process. Patients should be advised to cease smoking, as it may exacerbate symptoms, and they should receive referrals to sources of psychosocial support. Notably, physical therapy, focusing on exercise and postural training, is an essential component of the treatment plan, as these interventions can offer significant benefits in managing the course of the disease. [19]"}
{"id": "article-23508_36", "title": "Inflammatory Back Pain -- Pearls and Other Issues", "content": "A few key facts to remember about IBP are as follows: Timely recognition of IBP is crucial for initiating appropriate interventions and preventing complications associated with spondyloarthropathies. Regular monitoring of patients with IBP, including imaging and laboratory assessments, helps track disease progression and modify treatment strategies accordingly. Encouraging patients to adopt a healthy lifestyle, including regular exercise and smoking cessation, can contribute to symptom control and overall well-being. Screening individuals in high-risk groups, such as those with a family history or specific genetic markers, may aid in the early detection of IBP. A multidisciplinary approach involving rheumatologists, primary care providers, physical therapists, and other specialists enhances the overall management of IBP.", "contents": "Inflammatory Back Pain -- Pearls and Other Issues. A few key facts to remember about IBP are as follows: Timely recognition of IBP is crucial for initiating appropriate interventions and preventing complications associated with spondyloarthropathies. Regular monitoring of patients with IBP, including imaging and laboratory assessments, helps track disease progression and modify treatment strategies accordingly. Encouraging patients to adopt a healthy lifestyle, including regular exercise and smoking cessation, can contribute to symptom control and overall well-being. Screening individuals in high-risk groups, such as those with a family history or specific genetic markers, may aid in the early detection of IBP. A multidisciplinary approach involving rheumatologists, primary care providers, physical therapists, and other specialists enhances the overall management of IBP."}
{"id": "article-23508_37", "title": "Inflammatory Back Pain -- Pearls and Other Issues", "content": "Genetic factors, including the presence of HLA-B27, play a significant role in developing IBP. Understanding genetic predispositions can guide diagnostic and management strategies.", "contents": "Inflammatory Back Pain -- Pearls and Other Issues. Genetic factors, including the presence of HLA-B27, play a significant role in developing IBP. Understanding genetic predispositions can guide diagnostic and management strategies."}
{"id": "article-23508_38", "title": "Inflammatory Back Pain -- Enhancing Healthcare Team Outcomes", "content": "Managing IBP requires clinical skills, strategic planning, ethical considerations, shared responsibilities, effective communication, and coordinated care. An interprofessional team approach is paramount for optimizing patient outcomes and enhancing the overall quality of care.\u00a0Collaborative responsibilities among healthcare professionals, including rheumatologists, primary care providers, nurses, therapists, and pharmacists, are integral to effectively managing IBP.", "contents": "Inflammatory Back Pain -- Enhancing Healthcare Team Outcomes. Managing IBP requires clinical skills, strategic planning, ethical considerations, shared responsibilities, effective communication, and coordinated care. An interprofessional team approach is paramount for optimizing patient outcomes and enhancing the overall quality of care.\u00a0Collaborative responsibilities among healthcare professionals, including rheumatologists, primary care providers, nurses, therapists, and pharmacists, are integral to effectively managing IBP."}
{"id": "article-23508_39", "title": "Inflammatory Back Pain -- Enhancing Healthcare Team Outcomes", "content": "Healthcare professionals are responsible for educating patients about the nature of IBP, treatment options, potential complications, and the importance of lifestyle modifications. Interprofessional communication should support shared decision-making, involving patients in discussions about their care and treatment options.", "contents": "Inflammatory Back Pain -- Enhancing Healthcare Team Outcomes. Healthcare professionals are responsible for educating patients about the nature of IBP, treatment options, potential complications, and the importance of lifestyle modifications. Interprofessional communication should support shared decision-making, involving patients in discussions about their care and treatment options."}
{"id": "article-23508_40", "title": "Inflammatory Back Pain -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Inflammatory Back Pain -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}